Samlyn Capital’s Bristol-Myers Squibb BMY Stock Holding History

Samlyn Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,306,491	Closed	-$77.3M	–	123
2021 Q3	$77.3M	Sell	1,306,491 -568,213	-30%	-$37.4M	1.03%	27
2021 Q2	$125M	Buy	1,874,704 +307,938	+20%	+$20.1M	1.84%	16
2021 Q1	$98.9M	Buy	1,566,766 +59,678	+4%	+$3.71M	1.37%	27
2020 Q4	$93.5M	Buy	1,507,088 +770,667	+105%	+$47.4M	1.34%	18
2020 Q3	$44.4M	Buy	736,421 +234,653	+47%	+$14.1M	0.8%	45
2020 Q2	$29.5M	Buy	+501,768	New	+$30M	0.55%	58
2020 Q1	–	Sell	-763,174	Closed	-$49M	–	85
2019 Q4	$49M	Sell	763,174 -144,034	-16%	-$8.25M	1.03%	33
2019 Q3	$46M	Sell	907,208 -296,071	-25%	-$13.9M	1.12%	34
2019 Q2	$54.6M	Buy	1,203,279 +836,027	+228%	+$38.9M	1.15%	33
2019 Q1	$17.5M	Sell	367,252 -127,107	-26%	-$6.33M	0.41%	67
2018 Q4	$25.7M	Buy	+494,359	New	+$26.6M	0.61%	53

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Samlyn Capital's BMY Position: Q4 2021 in Review

Samlyn Capital sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 1,306,491 shares — an estimated $77.3M sold.

Samlyn Capital first reported a position in BMY in Q4 2018 and held it in 11 quarters. The position peaked at $125M in Q2 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Samlyn Capital reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
Samlyn Capital sold 1,306,491 Bristol-Myers Squibb shares in Q4 2021, an estimated $77.3M.
Samlyn Capital first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 11 quarters.
Samlyn Capital's Bristol-Myers Squibb position peaked at $125M in Q2 2021.
2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Samlyn Capital's 13F filing for Q4 2021, filed 14 Feb 2022.